Linda Carpenter

In this discussion, Linda Carpenter, a leading expert in psychiatry and chief of the Mood Disorders Program at Butler Hospital, dives into the groundbreaking ProLivRx device for treating difficult depression. She explains the innovative approach of neuromodulation and how ProLivRx differs from other treatments like TMS. The conversation includes insights on clinical trial results, the user-friendly design for at-home use, and considerations for patient selection. Carpenter also addresses monitoring and safety protocols, making this technology a potential game-changer in mental health care.

Linda Carpenter, psychiatry professor and chief of the Mood Disorders Program at Butler Hospital/Brown, explains a new FDA-approved device for hard-to-treat depression. She describes how peripheral sensory nerves are stimulated and contrasts this approach with TMS. The conversation covers device origins, clinical trial results, and safety in clear, concise terms.